Sarah Cannon-Minnie Pearl Cancer Center — Nashville, Tennessee

Sarah Cannon-Minnie Pearl Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon-Minnie Pearl Cancer Center has participated in 9 clinical trials.

Therapeutic areas: Colorectal Cancer, Fallopian Tube Cancer, Metastatic Cancer.

Sponsors: National Cancer Institute (NCI), Genzyme, a Sanofi Company, NCIC Clinical Trials Group.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon-Minnie Pearl Cancer Center?

Sarah Cannon-Minnie Pearl Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon-Minnie Pearl Cancer Center conducted?

Sarah Cannon-Minnie Pearl Cancer Center has 9 clinical trials on record. Their work covers Colorectal Cancer, Fallopian Tube Cancer, Metastatic Cancer.

Is Sarah Cannon-Minnie Pearl Cancer Center accredited by Crixeo Health?

Yes — Sarah Cannon-Minnie Pearl Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon-Minnie Pearl Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.